Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Inc (NASDAQ:THRX)

14.26
Delayed Data
As of Jul 30
 -1.36 / -8.71%
Today’s Change
10.58
Today|||52-Week Range
23.84
+0.78%
Year-to-Date

Today’s Trading

Previous close15.62
Today’s open15.32
Day’s range13.86 - 15.38
Volume1,083,056
Average volume (3 months)573,279
Market cap$1.8B
Dividend yield7.01%
Data as of 3:59pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+90.11%
Earnings growth (next 5 years)-464.61%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp+0.02+0.45%
FOLDAmicus Therapeutics ...-0.18-1.09%
PTCTPTC Therapeutics Inc-0.28-0.55%
ALDRAlder Biopharmaceuti...+0.26+0.57%
Data as of 4:14pm ET, 07/30/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts